Det nye forumet finner du her

Tilbake til: Farma og medisin
Innlegg av: Frontmasta (20.12.17 10:45 ), lest 5869 ganger
Ticker: NANO
Endret: 24.12.17 14:57

NANO - Luigi Costa & CO ............

reiser til Amerika i begynnelsen av januar 2018. Før avreisen må han børsmelde at 2 nye studier ble igangsatt i 2017.

Flybilletter er bestilt.........


____________________________

24.12.2017

You're having trouble now Costa.
The refusal of REK 3 weeks ago, and then you have to set up a new battle plan for what you need to talk about in San Francisco and Boston Januar 2018. Are you sending out a stock exchange announcement before the new year Costa ?

From the link in US

Nordic Nanovector ASA

Focused on development of Antibody-Radionuclide-Conjugates (ARC). Lead asset Betalutin, a novel anti-CD37 ARC (Lutetium-177) radioimmunotherapeutic for the treatment of Non-Hodgkin Lymphoma, entering pivotal Ph 2 PARADIGME trial in 4Q17...............